Rep. Pascrell, Sen. Menendez Sound New Alarms in COVID-19 Drug Politicization
July 03, 2020
July 03, 2020
WASHINGTON, July 3 -- Rep. Bill Pascrell Jr., D-New Jersey, issued the following news release:
Continuing their crusade against politicization of the COVID-19 drug approval process by the Trump Administration, U.S. Rep. Bill Pascrell, Jr. (D-NJ-09) and U.S. Sen. Bob Menendez (D-NJ) have written a new letter to U.S. Food and Drug Administration (FDA) Commissioner Stephen Hahn again urging the FDA to be guided by science and not political considerations in helping find a vaccine. In a . . .
Continuing their crusade against politicization of the COVID-19 drug approval process by the Trump Administration, U.S. Rep. Bill Pascrell, Jr. (D-NJ-09) and U.S. Sen. Bob Menendez (D-NJ) have written a new letter to U.S. Food and Drug Administration (FDA) Commissioner Stephen Hahn again urging the FDA to be guided by science and not political considerations in helping find a vaccine. In a . . .